| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.34e-05 | 206 | 76 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | methylated histone binding | 3.25e-04 | 86 | 76 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 3.55e-04 | 88 | 76 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | 7SK snRNA binding | 5.06e-04 | 9 | 76 | 2 | GO:0097322 | |
| GeneOntologyMolecularFunction | histone binding | 5.19e-04 | 265 | 76 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 6.31e-04 | 10 | 76 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | RNA polymerase III general transcription initiation factor activity | 1.09e-03 | 13 | 76 | 2 | GO:0000995 | |
| GeneOntologyBiologicalProcess | RNA splicing | FRA10AC1 SRSF4 PNN PRPF3 CDK13 CLK3 RBM15B ACIN1 PRPF38B ILDR1 RP9 PRPF40A THRAP3 LARP7 | 4.41e-09 | 502 | 77 | 14 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | FRA10AC1 SRSF4 PNN PRPF3 CDK13 RBM15B ACIN1 PRPF40A THRAP3 LARP7 | 8.55e-07 | 358 | 77 | 10 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | FRA10AC1 SRSF4 PNN PRPF3 CDK13 RBM15B ACIN1 PRPF40A THRAP3 LARP7 | 8.55e-07 | 358 | 77 | 10 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | FRA10AC1 SRSF4 PNN PRPF3 CDK13 RBM15B ACIN1 PRPF40A THRAP3 LARP7 | 9.46e-07 | 362 | 77 | 10 | GO:0000375 |
| GeneOntologyBiologicalProcess | mRNA processing | FRA10AC1 SRSF4 PNN PRPF3 CDK13 RBM15B ACIN1 PRPF38B PRPF40A THRAP3 LARP7 | 6.07e-06 | 551 | 77 | 11 | GO:0006397 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.23e-05 | 207 | 77 | 7 | GO:0043484 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.22e-04 | 129 | 77 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | positive regulation of insulin receptor signaling pathway | 2.30e-04 | 32 | 77 | 3 | GO:0046628 | |
| GeneOntologyCellularComponent | nuclear speck | SRSF4 PNN PRPF3 RBBP6 CDK13 CLK3 RBM15B ACIN1 RP9 CMYA5 CXXC1 PRPF40A THRAP3 | 4.78e-09 | 431 | 76 | 13 | GO:0016607 |
| GeneOntologyCellularComponent | nuclear body | SRSF4 TCF20 PNN SLF2 PRPF3 RBBP6 CDK13 CLK3 RBM15B ACIN1 RP9 CMYA5 SKIL CXXC1 PRPF40A THRAP3 | 1.22e-07 | 903 | 76 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CCNT2 MSH6 PNN PRPF3 CDK13 DBF4B TERB1 KMT2A ACIN1 MLLT1 PRPF38B BOD1L1 BICRAL BCOR CXXC1 PRPF40A JMJD1C THRAP3 LARP7 | 3.28e-07 | 1377 | 76 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | exon-exon junction complex | 5.86e-05 | 21 | 76 | 3 | GO:0035145 | |
| GeneOntologyCellularComponent | transferase complex | CCNT2 SLF2 CDK13 DBF4B TBC1D5 RBM15B KMT2A BOD1L1 PRKCZ REV3L BCOR CXXC1 | 1.74e-04 | 963 | 76 | 12 | GO:1990234 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.70e-04 | 157 | 76 | 5 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 3.89e-04 | 170 | 76 | 5 | GO:1902911 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 4.62e-04 | 9 | 76 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | methyltransferase complex | 6.50e-04 | 108 | 76 | 4 | GO:0034708 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 1.11e-03 | 56 | 76 | 3 | GO:0008023 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.38e-03 | 335 | 76 | 6 | GO:0061695 | |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 1.51e-03 | 16 | 76 | 2 | GO:0048188 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.70e-03 | 140 | 76 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 1.92e-03 | 18 | 76 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.58e-03 | 75 | 76 | 3 | GO:0035097 | |
| Domain | PHD | 3.31e-05 | 89 | 77 | 5 | SM00249 | |
| Domain | Znf_PHD | 3.68e-05 | 91 | 77 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.53e-05 | 95 | 77 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 4.76e-05 | 96 | 77 | 5 | PS01359 | |
| Domain | PWWP | 7.30e-05 | 20 | 77 | 3 | SM00293 | |
| Domain | PWWP | 1.12e-04 | 23 | 77 | 3 | PF00855 | |
| Domain | PWWP_dom | 1.12e-04 | 23 | 77 | 3 | IPR000313 | |
| Domain | PWWP | 1.28e-04 | 24 | 77 | 3 | PS50812 | |
| Domain | AT_hook | 1.84e-04 | 27 | 77 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.84e-04 | 27 | 77 | 3 | IPR017956 | |
| Domain | PHD | 2.60e-04 | 75 | 77 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 3.17e-04 | 79 | 77 | 4 | IPR019787 | |
| Domain | Znf_FYVE_PHD | 3.53e-04 | 147 | 77 | 5 | IPR011011 | |
| Domain | Znf_CXXC | 9.01e-04 | 11 | 77 | 2 | IPR002857 | |
| Domain | ZF_CXXC | 9.01e-04 | 11 | 77 | 2 | PS51058 | |
| Domain | zf-CXXC | 9.01e-04 | 11 | 77 | 2 | PF02008 | |
| Domain | ZnF_C2HC | 1.52e-03 | 55 | 77 | 3 | SM00343 | |
| Domain | Znf_CCHC | 1.52e-03 | 55 | 77 | 3 | IPR001878 | |
| Domain | Post-SET_dom | 1.94e-03 | 16 | 77 | 2 | IPR003616 | |
| Domain | PostSET | 1.94e-03 | 16 | 77 | 2 | SM00508 | |
| Domain | POST_SET | 1.94e-03 | 16 | 77 | 2 | PS50868 | |
| Domain | RRM | 2.03e-03 | 217 | 77 | 5 | SM00360 | |
| Domain | RRM_dom | 2.46e-03 | 227 | 77 | 5 | IPR000504 | |
| Domain | - | 3.36e-03 | 244 | 77 | 5 | 3.30.70.330 | |
| Domain | EPHD | 3.67e-03 | 22 | 77 | 2 | PS51805 | |
| Domain | Nucleotide-bd_a/b_plait | 4.26e-03 | 258 | 77 | 5 | IPR012677 | |
| Domain | - | 5.11e-03 | 26 | 77 | 2 | 4.10.60.10 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 2.14e-06 | 26 | 51 | 4 | M47439 | |
| Pathway | KEGG_SPLICEOSOME | 6.14e-06 | 127 | 51 | 6 | M2044 | |
| Pathway | WP_MRNA_PROCESSING | 2.99e-05 | 451 | 51 | 9 | MM15946 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.10e-04 | 212 | 51 | 6 | M14033 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.69e-04 | 77 | 51 | 4 | MM14670 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 3.44e-04 | 38 | 51 | 3 | MM17073 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.65e-04 | 94 | 51 | 4 | M1041 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 4.32e-04 | 41 | 51 | 3 | MM14876 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 4.64e-04 | 42 | 51 | 3 | M48018 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 5.24e-04 | 283 | 51 | 6 | M13087 | |
| Pathway | REACTOME_MRNA_SPLICING | 7.73e-04 | 201 | 51 | 5 | MM15411 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 8.22e-04 | 51 | 51 | 3 | M665 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 8.61e-04 | 118 | 51 | 4 | MM15588 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | CCNT2 GTF3C1 CDK13 KMT2A MLLT1 ZNF740 BOD1L1 SNAPC4 SKIL CXXC1 PPM1A | 8.89e-04 | 1022 | 51 | 11 | MM15436 |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 9.76e-04 | 13 | 51 | 2 | M47440 | |
| Pathway | WP_MRNA_PROCESSING | 1.10e-03 | 126 | 51 | 4 | M39406 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CEP170 CCNT2 MSH6 SRSF4 TCF20 GTF3C1 PNN PRPF3 RBBP6 NSD2 CLK3 GLYR1 U2SURP NEMF RBM15B ACIN1 PRPF38B ZCCHC17 RSRC2 CXXC1 PRPF40A THRAP3 OPA1 UNC13A | 5.99e-18 | 1082 | 77 | 24 | 38697112 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRSF4 TCF20 GTF3C1 PNN SLF2 PRPF3 RBBP6 NSD2 CDK13 GLYR1 U2SURP RBM15B UHRF1 KMT2A ACIN1 MLLT1 ZNF740 AATF BCOR SKIL CXXC1 PRPF40A TOR1AIP1 JMJD1C THRAP3 | 2.67e-17 | 1294 | 77 | 25 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CEP170 SRSF4 TCF20 PNN SLF2 PRPF3 RBBP6 NSD2 U2SURP RBM15B KMT2A ACIN1 MLLT1 AATF BOD1L1 RP9 BCOR PRPF40A TOR1AIP1 JMJD1C THRAP3 | 1.20e-15 | 954 | 77 | 21 | 36373674 |
| Pubmed | SRSF4 MAP1S PRPF3 RBBP6 CLK3 RBM15B UHRF1 KMT2A ACIN1 PRPF38B BOD1L1 CXXC1 THRAP3 | 1.29e-14 | 251 | 77 | 13 | 31076518 | |
| Pubmed | CEP170 CCNT2 MSH6 SRSF4 GTF3C1 PNN PRPF3 RBBP6 CLK3 U2SURP RBM15B ACIN1 PRPF38B RSRC2 PRPF40A THRAP3 LARP7 | 2.58e-13 | 713 | 77 | 17 | 29802200 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CEP170 MSH6 GTF3C1 PNN PRPF3 RBBP6 NSD2 CDK13 GLYR1 NEMF RBM15B UHRF1 ACIN1 AATF ZCCHC17 ZBTB11 LARP7 | 7.01e-13 | 759 | 77 | 17 | 35915203 |
| Pubmed | CEP170 MSH6 SRSF4 TCF20 GTF3C1 PNN NSD2 GLYR1 U2SURP OSBPL8 KMT2A ACIN1 AATF ZBTB11 PRPF40A LARP7 | 9.42e-13 | 653 | 77 | 16 | 22586326 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CCNT2 MSH6 TCF20 GTF3C1 MAP1S PNN RBBP6 CDK13 RBM15B KMT2A ACIN1 PRPF38B SNAPC4 BCOR PRPF40A THRAP3 ANKS1A | 9.57e-13 | 774 | 77 | 17 | 15302935 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK CEP170 MSH6 PNN PRPF3 RBBP6 TBC1D5 U2SURP CASP3 KMT2A ACIN1 PRPF38B BOD1L1 BCOR CAMSAP1 PRPF40A TOR1AIP1 ANKS1A | 1.66e-12 | 934 | 77 | 18 | 33916271 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SRSF4 PNN PRPF3 RBBP6 CDK13 CLK3 U2SURP RBM15B ACIN1 AATF ZCCHC17 RP9 RSRC2 PRPF40A THRAP3 LARP7 | 2.23e-11 | 807 | 77 | 16 | 22681889 |
| Pubmed | CEP170 SRSF4 TCF20 PNN PRPF3 RBBP6 UHRF1 ACIN1 PRPF40A THRAP3 LARP7 | 2.50e-11 | 274 | 77 | 11 | 34244482 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CEP170 MAP1S PNN RBBP6 CDK13 RBM15B PRPF38B ZCCHC17 MYO18B CAMSAP1 JMJD1C THRAP3 | 2.62e-11 | 361 | 77 | 12 | 26167880 |
| Pubmed | CCNT2 MSH6 TCF20 GTF3C1 PNN PRPF3 RBBP6 NSD2 CDK13 UHRF1 KMT2A ACIN1 PRPF38B BOD1L1 PRPF40A THRAP3 LARP7 | 6.60e-11 | 1014 | 77 | 17 | 32416067 | |
| Pubmed | CEP170 PNN NSD2 GLYR1 NEMF OSBPL8 ACIN1 AATF PRPF40A TOR1AIP1 LARP7 | 1.94e-10 | 332 | 77 | 11 | 25693804 | |
| Pubmed | CEP170 MSH6 TCF20 GTF3C1 PNN RBBP6 KMT2A ACIN1 BOD1L1 BCOR PRPF40A JMJD1C THRAP3 | 2.40e-10 | 549 | 77 | 13 | 38280479 | |
| Pubmed | SRSF4 GTF3C1 PNN PRPF3 RBBP6 GLYR1 U2SURP RBM15B KMT2A ACIN1 AATF PRPF40A TOR1AIP1 THRAP3 LARP7 | 4.82e-10 | 847 | 77 | 15 | 35850772 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CEP170 NHSL1 STOX2 TCF20 SLF2 CLK3 TBC1D5 OSBPL8 KMT2A BOD1L1 CAMSAP1 TMCC3 PPM1A FAM83B ANKS1A | 6.04e-10 | 861 | 77 | 15 | 36931259 |
| Pubmed | TNIK CEP170 CDK13 GLYR1 PEG3 NEMF RBM15B OSBPL8 UHRF1 KMT2A ACIN1 AATF PRPF38B ZCCHC17 RSRC2 PRPF40A THRAP3 LARP7 | 8.50e-10 | 1371 | 77 | 18 | 36244648 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MSH6 GTF3C1 PNN NSD2 GLYR1 U2SURP NEMF RBM15B UHRF1 ACIN1 BOD1L1 MYO18B CMYA5 PRPF40A TOR1AIP1 THRAP3 OPA1 LARP7 | 1.56e-09 | 1425 | 77 | 18 | 30948266 |
| Pubmed | MSH6 GTF3C1 PNN RBBP6 CDK13 U2SURP ACIN1 RP9 ZBTB11 PRPF40A THRAP3 OPA1 FAM83B | 2.03e-09 | 655 | 77 | 13 | 35819319 | |
| Pubmed | CEP170 MSH6 PRPF3 RBBP6 NSD2 MLLT1 ZNF740 BICRAL REV3L RSRC2 BCOR RALGAPA2 SKIL PRPF40A OPA1 LARP7 | 2.47e-09 | 1116 | 77 | 16 | 31753913 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CCNT2 SRSF4 PNN RBBP6 CDK13 CLK3 DBF4B ACIN1 MLLT1 RSRC2 PRPF40A THRAP3 LARP7 | 4.12e-09 | 695 | 77 | 13 | 23602568 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | MSH6 PNN PRPF3 GLYR1 U2SURP RBM15B KMT2A ACIN1 AATF PRPF40A THRAP3 LARP7 | 9.05e-09 | 605 | 77 | 12 | 28977666 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MSH6 TCF20 GTF3C1 NSD2 GLYR1 UHRF1 KMT2A BOD1L1 SNAPC4 BCOR ZBTB11 JMJD1C | 9.56e-09 | 608 | 77 | 12 | 36089195 |
| Pubmed | CCNT2 SRSF4 PNN RBBP6 U2SURP NEMF ACIN1 MLLT1 PRPF38B PRKCZ RSRC2 PRPF40A THRAP3 OPA1 LARP7 FAM83B | 1.18e-08 | 1247 | 77 | 16 | 27684187 | |
| Pubmed | 1.28e-08 | 195 | 77 | 8 | 19454010 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.37e-08 | 283 | 77 | 9 | 30585729 | |
| Pubmed | CEP170 CCNT2 MSH6 TCF20 GTF3C1 PRPF3 CDK13 U2SURP KMT2A PRPF38B BICRAL RSRC2 BCOR JMJD1C THRAP3 | 1.69e-08 | 1103 | 77 | 15 | 34189442 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CEP170 GTF3C1 PRPF3 NSD2 CDK13 GLYR1 TBC1D5 MYT1 NEMF PRPF38B BOD1L1 PRKCZ KATNAL1 PNPLA7 JMJD1C THRAP3 ANKS1A | 2.14e-08 | 1489 | 77 | 17 | 28611215 |
| Pubmed | 2.19e-08 | 14 | 77 | 4 | 20854876 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MSH6 SRSF4 PNN RBBP6 U2SURP OSBPL8 KMT2A ACIN1 AATF PRPF38B ZCCHC17 RP9 PRPF40A THRAP3 OPA1 LARP7 | 2.56e-08 | 1318 | 77 | 16 | 30463901 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CCNT2 MSH6 GTF3C1 PNN NSD2 UHRF1 KMT2A ACIN1 AATF ZBTB11 PRPF40A | 2.65e-08 | 533 | 77 | 11 | 30554943 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.26e-08 | 313 | 77 | 9 | 38270169 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 5.12e-08 | 330 | 77 | 9 | 33301849 | |
| Pubmed | SRSF4 PNN PRPF3 RBBP6 CLK3 U2SURP RBM15B ACIN1 PRPF38B RSRC2 PRPF40A THRAP3 | 7.17e-08 | 731 | 77 | 12 | 29298432 | |
| Pubmed | 7.26e-08 | 244 | 77 | 8 | 29884807 | ||
| Pubmed | FRA10AC1 GTF3C1 PNN NSD2 CDK13 U2SURP SCN9A KMT2A ACIN1 MLLT1 AATF BOD1L1 ZBTB11 CXXC1 THRAP3 LARP7 | 8.80e-08 | 1442 | 77 | 16 | 35575683 | |
| Pubmed | 1.02e-07 | 255 | 77 | 8 | 15324660 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.04e-07 | 477 | 77 | 10 | 31300519 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MSH6 LOXHD1 SRSF4 PNN PRPF3 CLK3 ACIN1 PRPF38B CMYA5 PRPF40A JMJD1C THRAP3 OPA1 PPM1A ANKS1A | 1.22e-07 | 1284 | 77 | 15 | 17353931 |
| Pubmed | 1.29e-07 | 263 | 77 | 8 | 34702444 | ||
| Pubmed | MSH6 RBBP6 NSD2 CDK13 CLK3 RBM15B OSBPL8 KMT2A MLLT1 AATF PRPF38B RSRC2 BCOR ZBTB11 LARP7 FAM83B | 1.46e-07 | 1497 | 77 | 16 | 31527615 | |
| Pubmed | 1.49e-07 | 268 | 77 | 8 | 33640491 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | PNN PRPF3 RBBP6 CDK13 CLK3 GLYR1 U2SURP UHRF1 AATF ZCCHC17 RP9 PRPF40A THRAP3 | 1.57e-07 | 949 | 77 | 13 | 36574265 |
| Pubmed | MSH6 PRPF3 RBBP6 CDK13 U2SURP ACIN1 BOD1L1 PRPF40A THRAP3 LARP7 | 1.78e-07 | 506 | 77 | 10 | 30890647 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.82e-07 | 184 | 77 | 7 | 32908313 | |
| Pubmed | MSH6 TCF20 GLYR1 MYT1 PEG3 UHRF1 ACIN1 ZNF740 AATF SNAPC4 SKIL CXXC1 | 2.10e-07 | 808 | 77 | 12 | 20412781 | |
| Pubmed | 2.24e-07 | 115 | 77 | 6 | 17332742 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MSH6 TCF20 GTF3C1 GLYR1 U2SURP UHRF1 ACIN1 AATF BOD1L1 ZBTB11 PRPF40A JMJD1C THRAP3 | 2.51e-07 | 989 | 77 | 13 | 36424410 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.89e-07 | 197 | 77 | 7 | 20811636 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 3.20e-07 | 410 | 77 | 9 | 26949251 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CEP170 TCF20 GTF3C1 PNN PRPF3 U2SURP UHRF1 ACIN1 AATF PRPF40A TOR1AIP1 THRAP3 FAM83B | 3.72e-07 | 1024 | 77 | 13 | 24711643 |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 4.63e-07 | 130 | 77 | 6 | 35545047 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 4.96e-07 | 432 | 77 | 9 | 23455922 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.08e-07 | 220 | 77 | 7 | 35785414 | |
| Pubmed | TNIK CEP170 TCF20 OSBPL8 CASP3 BOD1L1 RSRC2 CAMSAP1 TOR1AIP1 JMJD1C ANKS1A | 6.39e-07 | 733 | 77 | 11 | 34672954 | |
| Pubmed | 6.46e-07 | 222 | 77 | 7 | 37071664 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 9.91e-07 | 148 | 77 | 6 | 32538781 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.32e-06 | 358 | 77 | 8 | 32460013 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 1.50e-06 | 364 | 77 | 8 | 24778252 | |
| Pubmed | 1.55e-06 | 496 | 77 | 9 | 31343991 | ||
| Pubmed | CEP170 NSD2 GLYR1 UHRF1 KMT2A RSRC2 CAMSAP1 TOR1AIP1 THRAP3 LARP7 | 1.61e-06 | 645 | 77 | 10 | 25281560 | |
| Pubmed | 1.74e-06 | 503 | 77 | 9 | 16964243 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.74e-06 | 163 | 77 | 6 | 22113938 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.81e-06 | 259 | 77 | 7 | 30404004 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 2.12e-06 | 665 | 77 | 10 | 30457570 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 2.32e-06 | 269 | 77 | 7 | 29511261 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.69e-06 | 394 | 77 | 8 | 27248496 | |
| Pubmed | 2.95e-06 | 399 | 77 | 8 | 35987950 | ||
| Pubmed | 3.45e-06 | 103 | 77 | 5 | 32744500 | ||
| Pubmed | 3.61e-06 | 104 | 77 | 5 | 31365120 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CEP170 MSH6 GTF3C1 PNN PRPF3 RBBP6 CLK3 GLYR1 RBM15B ACIN1 AATF THRAP3 FAM83B | 3.62e-06 | 1257 | 77 | 13 | 36526897 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.67e-06 | 411 | 77 | 8 | 35182466 | |
| Pubmed | PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ. | 3.68e-06 | 47 | 77 | 4 | 29934401 | |
| Pubmed | 3.73e-06 | 14 | 77 | 3 | 26912663 | ||
| Pubmed | SRSF4 PNN RBBP6 CDK13 CLK3 PRPF38B ZCCHC17 PRPF40A THRAP3 LARP7 | 4.43e-06 | 723 | 77 | 10 | 34133714 | |
| Pubmed | 4.73e-06 | 50 | 77 | 4 | 37974198 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15541726 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 36435883 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17252016 | ||
| Pubmed | Molecular characterization of a novel nucleolar protein, pNO40. | 4.84e-06 | 2 | 77 | 2 | 12893261 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21953510 | ||
| Pubmed | Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia. | 4.84e-06 | 2 | 77 | 2 | 8378076 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19029444 | ||
| Pubmed | Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. | 4.84e-06 | 2 | 77 | 2 | 10490026 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CEP170 CCNT2 GTF3C1 MAP1S PNN CDK13 CLK3 OSBPL8 KMT2A MLLT1 THRAP3 | 5.13e-06 | 910 | 77 | 11 | 36736316 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MSH6 LOXHD1 GTF3C1 MLLT1 PRPF38B BOD1L1 REV3L ZBTB11 CXXC1 PPM1A | 5.19e-06 | 736 | 77 | 10 | 29676528 |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 5.19e-06 | 197 | 77 | 6 | 22365833 | |
| Pubmed | 6.71e-06 | 206 | 77 | 6 | 34185411 | ||
| Pubmed | 7.35e-06 | 601 | 77 | 9 | 33658012 | ||
| Pubmed | TNIK CEP170 NHSL1 MAP1S GLYR1 U2SURP OSBPL8 PRPF38B CAMSAP1 THRAP3 OPA1 UNC13A | 7.42e-06 | 1139 | 77 | 12 | 36417873 | |
| Pubmed | 7.49e-06 | 210 | 77 | 6 | 16565220 | ||
| Pubmed | TNIK CEP170 STOX2 TCF20 TBC1D5 BCOR CAMSAP1 THRAP3 OPA1 UNC13A ANKS1A | 8.74e-06 | 963 | 77 | 11 | 28671696 | |
| Pubmed | 9.61e-06 | 469 | 77 | 8 | 27634302 | ||
| Pubmed | 1.05e-05 | 339 | 77 | 7 | 30415952 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.09e-05 | 341 | 77 | 7 | 32971831 | |
| Pubmed | CEP170 MSH6 SRSF4 CLK3 U2SURP ACIN1 BOD1L1 KATNAL1 PRPF40A LARP7 | 1.18e-05 | 809 | 77 | 10 | 32129710 | |
| Pubmed | 1.20e-05 | 133 | 77 | 5 | 15144186 | ||
| Pubmed | 1.22e-05 | 347 | 77 | 7 | 16033648 | ||
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 1.25e-05 | 134 | 77 | 5 | 28695742 | |
| Interaction | SRPK2 interactions | CEP170 SRSF4 MAP1S PNN RBBP6 CDK13 CLK3 DBF4B GLYR1 U2SURP RBM15B ACIN1 AATF PRPF38B ZCCHC17 MYO18B RSRC2 CAMSAP1 PRPF40A JMJD1C THRAP3 LARP7 | 1.57e-14 | 717 | 77 | 22 | int:SRPK2 |
| Interaction | SRSF4 interactions | SRSF4 PNN RBBP6 NSD2 CDK13 CLK3 GLYR1 U2SURP KMT2A ACIN1 AATF ZBTB11 THRAP3 LARP7 | 7.02e-12 | 300 | 77 | 14 | int:SRSF4 |
| Interaction | SMC5 interactions | CEP170 SRSF4 TCF20 PNN SLF2 PRPF3 RBBP6 NSD2 U2SURP RBM15B KMT2A ACIN1 MLLT1 AATF BOD1L1 RP9 REV3L BCOR PRPF40A TOR1AIP1 JMJD1C THRAP3 | 1.20e-11 | 1000 | 77 | 22 | int:SMC5 |
| Interaction | MECP2 interactions | CEP170 CCNT2 MSH6 SRSF4 TCF20 GTF3C1 PNN PRPF3 RBBP6 NSD2 CLK3 GLYR1 U2SURP NEMF RBM15B ACIN1 PRPF38B ZCCHC17 RSRC2 CXXC1 PRPF40A THRAP3 OPA1 UNC13A | 3.54e-11 | 1287 | 77 | 24 | int:MECP2 |
| Interaction | SRSF6 interactions | SRSF4 PNN RBBP6 NSD2 CDK13 CLK3 GLYR1 U2SURP KMT2A ACIN1 AATF PRPF38B ZCCHC17 ZBTB11 THRAP3 LARP7 | 6.03e-11 | 503 | 77 | 16 | int:SRSF6 |
| Interaction | DDX23 interactions | MSH6 SRSF4 PNN PRPF3 RBBP6 CDK13 U2SURP ACIN1 MLLT1 AATF RP9 RSRC2 PRPF40A THRAP3 LARP7 | 3.30e-10 | 480 | 77 | 15 | int:DDX23 |
| Interaction | HECTD1 interactions | CEP170 MSH6 GTF3C1 PNN PRPF3 RBBP6 NSD2 CDK13 GLYR1 U2SURP NEMF RBM15B UHRF1 ACIN1 AATF PRPF38B ZCCHC17 ZBTB11 PRPF40A LARP7 | 5.10e-10 | 984 | 77 | 20 | int:HECTD1 |
| Interaction | NUP43 interactions | CCNT2 TCF20 PNN SLF2 RBBP6 NSD2 GLYR1 KMT2A ACIN1 AATF BOD1L1 BCOR ZBTB11 JMJD1C LARP7 PPM1A | 1.43e-09 | 625 | 77 | 16 | int:NUP43 |
| Interaction | SNRNP70 interactions | CEP170 CCNT2 MSH6 SRSF4 GTF3C1 PNN PRPF3 RBBP6 CLK3 U2SURP RBM15B CASP3 ACIN1 PRPF38B RSRC2 SKIL PRPF40A THRAP3 LARP7 | 3.52e-09 | 984 | 77 | 19 | int:SNRNP70 |
| Interaction | IFI16 interactions | CEP170 MSH6 SRSF4 PNN PRPF3 NSD2 GLYR1 U2SURP NEMF OSBPL8 ACIN1 AATF RP9 PRPF40A TOR1AIP1 LARP7 | 9.51e-09 | 714 | 77 | 16 | int:IFI16 |
| Interaction | DHX8 interactions | SRSF4 TCF20 PNN PRPF3 RBBP6 CDK13 U2SURP RSRC2 BCOR PRPF40A THRAP3 | 1.40e-08 | 292 | 77 | 11 | int:DHX8 |
| Interaction | SIRT7 interactions | CEP170 MSH6 SRSF4 TCF20 GTF3C1 PNN NSD2 GLYR1 U2SURP OSBPL8 KMT2A ACIN1 AATF ZBTB11 PRPF40A LARP7 | 1.69e-08 | 744 | 77 | 16 | int:SIRT7 |
| Interaction | NAA40 interactions | TNIK CEP170 MSH6 PNN PRPF3 RBBP6 TBC1D5 U2SURP CASP3 KMT2A ACIN1 PRPF38B BOD1L1 BCOR CAMSAP1 PRPF40A TOR1AIP1 ANKS1A | 2.07e-08 | 978 | 77 | 18 | int:NAA40 |
| Interaction | RNF151 interactions | 2.26e-08 | 123 | 77 | 8 | int:RNF151 | |
| Interaction | MYCN interactions | CEP170 SRSF4 TCF20 GTF3C1 PNN PRPF3 RBBP6 CDK13 GLYR1 U2SURP RBM15B UHRF1 KMT2A ACIN1 AATF PRPF38B ZCCHC17 RP9 PRPF40A THRAP3 LARP7 | 2.71e-08 | 1373 | 77 | 21 | int:MYCN |
| Interaction | YWHAG interactions | CEP170 NHSL1 STOX2 PNN CLK3 TBC1D5 RBM15B OSBPL8 CASP3 KMT2A ACIN1 PRPF38B BOD1L1 PRKCZ CAMSAP1 PRPF40A THRAP3 TMCC3 FAM83B ANKS1A | 2.93e-08 | 1248 | 77 | 20 | int:YWHAG |
| Interaction | GLDC interactions | CEP170 SRSF4 TCF20 PNN PRPF3 RBBP6 UHRF1 ACIN1 PRPF40A THRAP3 LARP7 | 3.70e-08 | 321 | 77 | 11 | int:GLDC |
| Interaction | DOT1L interactions | SRSF4 GTF3C1 PNN PRPF3 RBBP6 GLYR1 U2SURP RBM15B KMT2A ACIN1 MLLT1 AATF PRPF40A TOR1AIP1 THRAP3 LARP7 | 5.24e-08 | 807 | 77 | 16 | int:DOT1L |
| Interaction | CIT interactions | TNIK CEP170 MSH6 TCF20 PNN PRPF3 RBBP6 DBF4B GLYR1 UHRF1 KMT2A ACIN1 AATF PRPF38B BOD1L1 RP9 CMYA5 RALGAPA2 PRPF40A TOR1AIP1 THRAP3 | 6.92e-08 | 1450 | 77 | 21 | int:CIT |
| Interaction | SRSF7 interactions | SRSF4 GTF3C1 PNN PRPF3 RBBP6 CLK3 GLYR1 U2SURP ACIN1 PRPF40A THRAP3 LARP7 | 7.06e-08 | 425 | 77 | 12 | int:SRSF7 |
| Interaction | SNRNP40 interactions | CCNT2 TCF20 PNN PRPF3 RBBP6 NSD2 KMT2A ACIN1 AATF RP9 BCOR ZBTB11 PRPF40A LARP7 | 1.15e-07 | 637 | 77 | 14 | int:SNRNP40 |
| Interaction | TERF2IP interactions | TCF20 GTF3C1 RBBP6 NSD2 CDK13 U2SURP KMT2A BOD1L1 RSRC2 BCOR PRPF40A TOR1AIP1 LARP7 | 1.57e-07 | 552 | 77 | 13 | int:TERF2IP |
| Interaction | CLK3 interactions | 1.58e-07 | 220 | 77 | 9 | int:CLK3 | |
| Interaction | NKAPD1 interactions | 1.84e-07 | 161 | 77 | 8 | int:NKAPD1 | |
| Interaction | CENPA interactions | MSH6 TCF20 GTF3C1 SLF2 NSD2 GLYR1 UHRF1 KMT2A MLLT1 AATF TOR1AIP1 | 1.88e-07 | 377 | 77 | 11 | int:CENPA |
| Interaction | MEN1 interactions | SRSF4 TCF20 GTF3C1 PNN PRPF3 RBBP6 GLYR1 U2SURP KMT2A ACIN1 AATF BOD1L1 CXXC1 PRPF40A TOR1AIP1 JMJD1C THRAP3 | 2.57e-07 | 1029 | 77 | 17 | int:MEN1 |
| Interaction | BRD3 interactions | GTF3C1 PNN PRPF3 RBBP6 NSD2 UHRF1 KMT2A ACIN1 ZNF740 RSRC2 PRPF40A LARP7 | 3.57e-07 | 494 | 77 | 12 | int:BRD3 |
| Interaction | SNIP1 interactions | SRSF4 PNN PRPF3 CDK13 CLK3 RBM15B ACIN1 AATF PRPF40A THRAP3 TMCC3 | 5.12e-07 | 417 | 77 | 11 | int:SNIP1 |
| Interaction | CSNK2A1 interactions | CEP170 MSH6 PNN OSBPL8 KMT2A ACIN1 MLLT1 ZCCHC17 RP9 PRKCZ SNAPC4 BCOR PRPF40A TOR1AIP1 THRAP3 LARP7 | 5.20e-07 | 956 | 77 | 16 | int:CSNK2A1 |
| Interaction | H2AJ interactions | 5.57e-07 | 127 | 77 | 7 | int:H2AJ | |
| Interaction | RNPS1 interactions | SRSF4 GTF3C1 PNN PRPF3 RBBP6 CLK3 ACIN1 AATF ZCCHC17 PRPF40A THRAP3 | 6.17e-07 | 425 | 77 | 11 | int:RNPS1 |
| Interaction | YWHAH interactions | CEP170 NHSL1 STOX2 TCF20 PNN SLF2 CLK3 TBC1D5 RBM15B OSBPL8 KMT2A BOD1L1 PRKCZ CAMSAP1 TMCC3 FAM83B ANKS1A | 6.73e-07 | 1102 | 77 | 17 | int:YWHAH |
| Interaction | CLK2 interactions | 7.91e-07 | 195 | 77 | 8 | int:CLK2 | |
| Interaction | THRAP3 interactions | TNIK SRSF4 PNN PRPF3 RBBP6 NSD2 CLK3 ACIN1 AATF THRAP3 LARP7 | 9.27e-07 | 443 | 77 | 11 | int:THRAP3 |
| Interaction | ZNF330 interactions | MSH6 TCF20 GTF3C1 NSD2 GLYR1 UHRF1 KMT2A MLLT1 AATF ZBTB11 LARP7 | 9.91e-07 | 446 | 77 | 11 | int:ZNF330 |
| Interaction | JMJD6 interactions | 1.15e-06 | 205 | 77 | 8 | int:JMJD6 | |
| Interaction | OBSL1 interactions | TCF20 GTF3C1 PNN PRPF3 GLYR1 U2SURP NEMF UHRF1 ACIN1 AATF PRPF38B CXXC1 PRPF40A THRAP3 LARP7 | 1.35e-06 | 902 | 77 | 15 | int:OBSL1 |
| Interaction | CEBPB interactions | CEP170 MSH6 SRSF4 TCF20 PNN PRPF3 CDK13 U2SURP UHRF1 ACIN1 MLLT1 AATF RP9 SKIL PRPF40A TOR1AIP1 LRRD1 THRAP3 OPA1 | 1.44e-06 | 1443 | 77 | 19 | int:CEBPB |
| Interaction | SRSF5 interactions | SRSF4 GTF3C1 PRPF3 NSD2 CDK13 CLK3 GLYR1 U2SURP KMT2A ZBTB11 LARP7 | 1.79e-06 | 474 | 77 | 11 | int:SRSF5 |
| Interaction | H2BC8 interactions | MSH6 TCF20 GTF3C1 NSD2 GLYR1 UHRF1 KMT2A RP9 RSRC2 BCOR CXXC1 TOR1AIP1 | 1.79e-06 | 576 | 77 | 12 | int:H2BC8 |
| Interaction | RNF113A interactions | MSH6 GTF3C1 PNN RBBP6 CDK13 U2SURP ACIN1 RP9 ZBTB11 PRPF40A THRAP3 OPA1 FAM83B | 2.00e-06 | 692 | 77 | 13 | int:RNF113A |
| Interaction | TOP1 interactions | MSH6 TCF20 GTF3C1 PNN PRPF3 RBBP6 NSD2 CASP3 KMT2A ACIN1 PRPF40A THRAP3 LARP7 | 2.13e-06 | 696 | 77 | 13 | int:TOP1 |
| Interaction | CHD4 interactions | MSH6 TCF20 PNN PRPF3 RBBP6 NSD2 GLYR1 U2SURP RBM15B KMT2A ACIN1 CXXC1 PRPF40A THRAP3 LARP7 | 2.20e-06 | 938 | 77 | 15 | int:CHD4 |
| Interaction | CSNK2A2 interactions | CEP170 TCF20 GTF3C1 PNN OSBPL8 KMT2A ZCCHC17 RP9 SNAPC4 BCOR PRPF40A THRAP3 LARP7 | 3.00e-06 | 718 | 77 | 13 | int:CSNK2A2 |
| Interaction | ZCCHC10 interactions | 3.30e-06 | 236 | 77 | 8 | int:ZCCHC10 | |
| Interaction | SUPT5H interactions | CCNT2 MSH6 TCF20 GTF3C1 PNN U2SURP KMT2A ACIN1 JMJD1C THRAP3 | 3.39e-06 | 408 | 77 | 10 | int:SUPT5H |
| Interaction | CEBPA interactions | CEP170 CCNT2 MSH6 TCF20 GTF3C1 PNN PRPF3 CDK13 U2SURP KMT2A ACIN1 PRPF38B BICRAL RSRC2 BCOR JMJD1C THRAP3 | 3.57e-06 | 1245 | 77 | 17 | int:CEBPA |
| Interaction | ANKRD50 interactions | 3.59e-06 | 108 | 77 | 6 | int:ANKRD50 | |
| Interaction | ZC3H14 interactions | 3.78e-06 | 169 | 77 | 7 | int:ZC3H14 | |
| Interaction | BARD1 interactions | 3.87e-06 | 323 | 77 | 9 | int:BARD1 | |
| Interaction | AR interactions | TCF20 PNN PRPF3 NSD2 U2SURP CASP3 UHRF1 KMT2A ACIN1 AATF BCOR SKIL PRPF40A JMJD1C THRAP3 | 4.36e-06 | 992 | 77 | 15 | int:AR |
| Interaction | PRP4K interactions | 4.49e-06 | 329 | 77 | 9 | int:PRP4K | |
| Interaction | TRA2A interactions | 4.60e-06 | 330 | 77 | 9 | int:TRA2A | |
| Interaction | H3-3A interactions | MSH6 TCF20 GTF3C1 NSD2 GLYR1 UHRF1 KMT2A BOD1L1 SNAPC4 BCOR ZBTB11 JMJD1C THRAP3 | 4.76e-06 | 749 | 77 | 13 | int:H3-3A |
| Interaction | IFI27L1 interactions | 4.93e-06 | 65 | 77 | 5 | int:IFI27L1 | |
| Interaction | TERF2 interactions | 5.86e-06 | 340 | 77 | 9 | int:TERF2 | |
| Interaction | CAMKV interactions | 5.99e-06 | 118 | 77 | 6 | int:CAMKV | |
| Interaction | H3C1 interactions | MSH6 GTF3C1 PRPF3 NSD2 CDK13 GLYR1 U2SURP UHRF1 KMT2A MLLT1 CAMSAP1 JMJD1C THRAP3 LARP7 | 7.00e-06 | 901 | 77 | 14 | int:H3C1 |
| Interaction | ZBTB2 interactions | 8.04e-06 | 450 | 77 | 10 | int:ZBTB2 | |
| Interaction | SRPK3 interactions | 8.17e-06 | 190 | 77 | 7 | int:SRPK3 | |
| Interaction | PPIG interactions | 9.15e-06 | 127 | 77 | 6 | int:PPIG | |
| Interaction | RAD18 interactions | SRSF4 SLF2 PRPF3 RBBP6 CLK3 RBM15B UHRF1 ACIN1 PRPF38B THRAP3 | 9.20e-06 | 457 | 77 | 10 | int:RAD18 |
| Interaction | EPB41L3 interactions | 9.35e-06 | 272 | 77 | 8 | int:EPB41L3 | |
| Interaction | TRIR interactions | 9.36e-06 | 74 | 77 | 5 | int:TRIR | |
| Interaction | NCL interactions | CEP170 MSH6 GTF3C1 PNN PRPF3 NSD2 U2SURP SCN9A KMT2A AATF PRKCZ THRAP3 LARP7 | 9.41e-06 | 798 | 77 | 13 | int:NCL |
| Interaction | SF3A2 interactions | 9.60e-06 | 273 | 77 | 8 | int:SF3A2 | |
| Interaction | XRCC6 interactions | MSH6 TCF20 PRPF3 RBBP6 NSD2 GLYR1 KMT2A ACIN1 BOD1L1 SKIL PRPF40A JMJD1C THRAP3 LARP7 | 9.79e-06 | 928 | 77 | 14 | int:XRCC6 |
| Interaction | SRSF1 interactions | MSH6 SRSF4 CDK13 CLK3 GLYR1 U2SURP AATF ZBTB11 PRPF40A THRAP3 LARP7 | 1.04e-05 | 570 | 77 | 11 | int:SRSF1 |
| Interaction | GSK3A interactions | TNIK NHSL1 PNN U2SURP ACIN1 PRKCZ CAMSAP1 PRPF40A THRAP3 ANKS1A | 1.05e-05 | 464 | 77 | 10 | int:GSK3A |
| Interaction | NKAP interactions | 1.14e-05 | 132 | 77 | 6 | int:NKAP | |
| Interaction | H2BC21 interactions | MSH6 TCF20 PNN NSD2 DBF4B GLYR1 UHRF1 KMT2A MLLT1 BCOR JMJD1C LARP7 | 1.23e-05 | 696 | 77 | 12 | int:H2BC21 |
| Interaction | SRSF11 interactions | 1.26e-05 | 203 | 77 | 7 | int:SRSF11 | |
| Interaction | KRR1 interactions | 1.40e-05 | 379 | 77 | 9 | int:KRR1 | |
| Interaction | PSENEN interactions | 1.46e-05 | 81 | 77 | 5 | int:PSENEN | |
| Interaction | THOC1 interactions | 1.57e-05 | 210 | 77 | 7 | int:THOC1 | |
| Interaction | DDX21 interactions | SRSF4 PNN PRPF3 NSD2 GLYR1 U2SURP ACIN1 AATF ZCCHC17 PRPF40A THRAP3 LARP7 | 1.68e-05 | 718 | 77 | 12 | int:DDX21 |
| Interaction | SNRPA1 interactions | 1.90e-05 | 300 | 77 | 8 | int:SNRPA1 | |
| Interaction | ACIN1 interactions | 1.94e-05 | 301 | 77 | 8 | int:ACIN1 | |
| Interaction | EIF4A3 interactions | 1.97e-05 | 499 | 77 | 10 | int:EIF4A3 | |
| Interaction | PNN interactions | 1.99e-05 | 302 | 77 | 8 | int:PNN | |
| Interaction | PSME3 interactions | 2.06e-05 | 398 | 77 | 9 | int:PSME3 | |
| Interaction | SAP18 interactions | 2.14e-05 | 305 | 77 | 8 | int:SAP18 | |
| Interaction | RNF2 interactions | GTF3C1 CDK13 GLYR1 CASP3 UHRF1 KMT2A ACIN1 MLLT1 ZNF740 BCOR CXXC1 THRAP3 LARP7 | 2.24e-05 | 866 | 77 | 13 | int:RNF2 |
| Interaction | H1-1 interactions | NSD2 GLYR1 U2SURP AATF PRKCZ REV3L CMYA5 ZBTB11 THRAP3 LARP7 | 2.25e-05 | 507 | 77 | 10 | int:H1-1 |
| Interaction | PURG interactions | 2.30e-05 | 223 | 77 | 7 | int:PURG | |
| Interaction | ARRDC3 interactions | 2.37e-05 | 224 | 77 | 7 | int:ARRDC3 | |
| Interaction | CSNK2B interactions | CEP170 U2SURP OSBPL8 KMT2A ZCCHC17 RP9 PRKCZ SNAPC4 BCOR THRAP3 LARP7 | 2.44e-05 | 625 | 77 | 11 | int:CSNK2B |
| Interaction | CCNT1 interactions | 2.44e-05 | 225 | 77 | 7 | int:CCNT1 | |
| Interaction | ZC3H18 interactions | SRSF4 PNN PRPF3 RBBP6 CLK3 U2SURP RBM15B ACIN1 PRPF38B RSRC2 BCOR PRPF40A THRAP3 | 2.55e-05 | 877 | 77 | 13 | int:ZC3H18 |
| Interaction | NFKBIL1 interactions | 2.85e-05 | 93 | 77 | 5 | int:NFKBIL1 | |
| Interaction | HABP4 interactions | 2.94e-05 | 156 | 77 | 6 | int:HABP4 | |
| Interaction | LINC02910 interactions | 3.16e-05 | 95 | 77 | 5 | int:LINC02910 | |
| Interaction | WWTR1 interactions | 3.26e-05 | 422 | 77 | 9 | int:WWTR1 | |
| Interaction | CBX3 interactions | TCF20 GTF3C1 PRPF3 RBBP6 NSD2 GLYR1 UHRF1 KMT2A RP9 BCOR TOR1AIP1 | 3.30e-05 | 646 | 77 | 11 | int:CBX3 |
| Interaction | MKI67 interactions | SRSF4 GTF3C1 PNN PRPF3 NSD2 CDK13 UHRF1 KMT2A ACIN1 CXXC1 OPA1 | 3.39e-05 | 648 | 77 | 11 | int:MKI67 |
| Interaction | CPNE4 interactions | 3.66e-05 | 49 | 77 | 4 | int:CPNE4 | |
| Interaction | LARP4B interactions | 3.68e-05 | 240 | 77 | 7 | int:LARP4B | |
| Interaction | BRD2 interactions | 3.70e-05 | 429 | 77 | 9 | int:BRD2 | |
| Interaction | LUC7L interactions | 3.88e-05 | 242 | 77 | 7 | int:LUC7L | |
| Interaction | SNRPC interactions | 4.51e-05 | 440 | 77 | 9 | int:SNRPC | |
| GeneFamily | PWWP domain containing | 2.45e-05 | 22 | 47 | 3 | 1147 | |
| GeneFamily | PHD finger proteins | 8.69e-05 | 90 | 47 | 4 | 88 | |
| GeneFamily | Zinc fingers CXXC-type | 4.29e-04 | 12 | 47 | 2 | 136 | |
| GeneFamily | RNA binding motif containing | 2.25e-03 | 213 | 47 | 4 | 725 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.52e-03 | 34 | 47 | 2 | 487 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.38e-03 | 53 | 47 | 2 | 532 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CCNT2 PNN SLF2 RBBP6 CDK13 U2SURP NEMF OSBPL8 KMT2A PRPF38B BOD1L1 REV3L RSRC2 PRPF40A TOR1AIP1 JMJD1C THRAP3 PPM1A | 2.34e-07 | 1492 | 77 | 18 | M40023 |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 3.08e-07 | 223 | 77 | 8 | M17621 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CEP170 FRA10AC1 STOX2 PNN NEMF OSBPL8 PRPF38B REV3L RSRC2 ZBTB11 OPA1 LARP7 | 4.55e-07 | 656 | 77 | 12 | M18979 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | TNIK PRPF3 RBBP6 CASP3 BOD1L1 RALGAPA2 ZBTB11 JMJD1C OPA1 TMCC3 PPM1A | 4.67e-06 | 680 | 77 | 11 | M41089 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 4.95e-06 | 432 | 77 | 9 | M41149 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | NHSL1 MSH6 STOX2 SLF2 NSD2 DBF4B OSBPL8 BICRAL BCOR TOR1AIP1 OPA1 PPM1A | 1.08e-05 | 892 | 77 | 12 | M18120 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 1.54e-05 | 378 | 77 | 8 | M41174 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | MSH6 PNN RBBP6 U2SURP ACIN1 PRPF38B REV3L RSRC2 SKIL PRPF40A | 1.87e-05 | 644 | 77 | 10 | M41717 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 2.40e-05 | 195 | 77 | 6 | M13736 | |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_UP | 2.62e-05 | 198 | 77 | 6 | M7219 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 2.69e-05 | 199 | 77 | 6 | M5251 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN | 2.69e-05 | 199 | 77 | 6 | M8707 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 2.77e-05 | 200 | 77 | 6 | M6447 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 3.79e-05 | 429 | 77 | 8 | M29 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | MSH6 PNN RBBP6 U2SURP NEMF OSBPL8 BOD1L1 CAMSAP1 ZBTB11 PRPF40A | 4.85e-05 | 721 | 77 | 10 | M10237 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | CCNT2 MSH6 ZNF134 TCF20 PNN RBBP6 NSD2 CDK13 TBC1D5 CASP3 AATF PRPF40A LARP7 PPM1A | 4.88e-05 | 1394 | 77 | 14 | M9585 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CCNT2 SLF2 RBBP6 CDK13 TBC1D5 U2SURP SCN9A RBM15B OSBPL8 KMT2A PRPF38B CAMSAP1 OPA1 | 4.96e-05 | 1215 | 77 | 13 | M41122 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 6.49e-05 | 143 | 77 | 5 | M9149 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_DN | 6.90e-05 | 344 | 77 | 7 | M2239 | |
| Coexpression | FISCHER_DREAM_TARGETS | MSH6 PNN SLF2 RBBP6 NSD2 DBF4B UHRF1 TOR1AIP1 THRAP3 OPA1 LARP7 | 1.20e-04 | 969 | 77 | 11 | M149 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.42e-04 | 519 | 77 | 8 | M3395 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP | 1.43e-04 | 169 | 77 | 5 | M40877 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 1.69e-04 | 680 | 77 | 9 | MM456 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 1.77e-04 | 177 | 77 | 5 | M9401 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP | 1.82e-04 | 178 | 77 | 5 | M8996 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.94e-04 | 543 | 77 | 8 | MM997 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CEP170 MSH6 CDK13 U2SURP OSBPL8 BICRAL REV3L ZBTB11 OPA1 ANKS1A | 1.99e-04 | 856 | 77 | 10 | M4500 |
| Coexpression | GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP | 2.28e-04 | 187 | 77 | 5 | M4714 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 2.95e-04 | 578 | 77 | 8 | M2368 | |
| Coexpression | GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP | 3.04e-04 | 199 | 77 | 5 | M3391 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 3.04e-04 | 199 | 77 | 5 | M9501 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN | 3.04e-04 | 199 | 77 | 5 | M6172 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 3.11e-04 | 200 | 77 | 5 | M8032 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 3.11e-04 | 200 | 77 | 5 | M8030 | |
| Coexpression | GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP | 3.11e-04 | 200 | 77 | 5 | M3251 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 3.11e-04 | 200 | 77 | 5 | M5851 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKCELL_DN | 3.11e-04 | 200 | 77 | 5 | M4838 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 3.11e-04 | 200 | 77 | 5 | M4016 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 3.11e-04 | 200 | 77 | 5 | M6611 | |
| Coexpression | GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP | 3.11e-04 | 200 | 77 | 5 | M3419 | |
| Coexpression | GSE557_WT_VS_CIITA_KO_DC_DN | 3.11e-04 | 200 | 77 | 5 | M6008 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 3.66e-04 | 597 | 77 | 8 | MM1309 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 4.22e-04 | 610 | 77 | 8 | M3854 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | FRA10AC1 SEMA6D GTF3C1 U2SURP PEG3 OSBPL8 KATNAL1 TOR1AIP1 TMCC3 PPM1A | 4.39e-04 | 946 | 77 | 10 | M39169 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 4.42e-04 | 466 | 77 | 7 | M13522 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MSH6 PNN RBBP6 NSD2 NEMF CASP3 PRPF38B BOD1L1 ZCCHC17 PNPLA7 REV3L RSRC2 CAMSAP1 PRPF40A THRAP3 LARP7 | 9.16e-06 | 1257 | 77 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.69e-05 | 311 | 77 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.18e-05 | 532 | 77 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.30e-05 | 259 | 77 | 7 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | MSH6 PNN RBBP6 NSD2 NEMF CASP3 PRPF38B BOD1L1 ZCCHC17 PNPLA7 REV3L RSRC2 CAMSAP1 PRPF40A THRAP3 LARP7 | 5.69e-05 | 1459 | 77 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.90e-05 | 186 | 77 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | STOX2 PNN NSD2 PEG3 RBM15B CASP3 UHRF1 PRPF38B BOD1L1 REV3L BCOR CAMSAP1 RALGAPA2 THRAP3 LARP7 | 1.03e-04 | 1370 | 77 | 15 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | STOX2 PNN RBBP6 TBC1D5 MYT1 U2SURP NEMF UHRF1 PRPF38B BOD1L1 RP9 REV3L | 2.19e-04 | 989 | 77 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | STOX2 GTF3C1 PEG3 CASP3 ACIN1 MLLT1 KATNAL1 RSRC2 CXXC1 PRPF40A LARP7 | 2.21e-04 | 843 | 77 | 11 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.96e-04 | 469 | 77 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274 | 3.36e-04 | 256 | 77 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F | |
| CoexpressionAtlas | alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3 | 3.71e-04 | 367 | 77 | 7 | GSM399391_500 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.14e-11 | 197 | 77 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.51e-08 | 199 | 77 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.71e-08 | 200 | 77 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 194 | 77 | 6 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-06 | 200 | 77 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.31e-06 | 200 | 77 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.15e-05 | 170 | 77 | 5 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 176 | 77 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 1.48e-05 | 179 | 77 | 5 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 1.56e-05 | 181 | 77 | 5 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.78e-05 | 186 | 77 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 188 | 77 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.07e-05 | 192 | 77 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.34e-05 | 197 | 77 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.40e-05 | 198 | 77 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.40e-05 | 198 | 77 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-05 | 198 | 77 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.46e-05 | 199 | 77 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.46e-05 | 199 | 77 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 2.46e-05 | 199 | 77 | 5 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.52e-05 | 200 | 77 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.11e-05 | 132 | 77 | 4 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.11e-05 | 132 | 77 | 4 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.40e-06 | 195 | 77 | 7 | 6979_DN | |
| Drug | Clozapine | 6.69e-06 | 390 | 77 | 9 | ctd:D003024 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 3.45e-04 | 11 | 75 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | leukemia | 3.76e-04 | 55 | 75 | 3 | C0023418 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 5.88e-04 | 64 | 75 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | Tourette syndrome, schizophrenia | 9.50e-04 | 18 | 75 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | diet measurement, body mass index | 1.18e-03 | 20 | 75 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 2.08e-03 | 99 | 75 | 3 | EFO_0004639, EFO_0008595 | |
| Disease | Disorder of eye | 2.11e-03 | 212 | 75 | 4 | C0015397 | |
| Disease | Adenoid Cystic Carcinoma | 2.14e-03 | 100 | 75 | 3 | C0010606 | |
| Disease | cytotoxicity measurement, response to clozapine | 2.48e-03 | 29 | 75 | 2 | EFO_0006952, GO_0097338 | |
| Disease | Bilateral Wilms Tumor | 2.48e-03 | 29 | 75 | 2 | C2930471 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAAEKSSKHGAEDRT | 606 | Q9UPW8 | |
| HSPRKSSSISEEKGD | 201 | Q9UKV3 | |
| KTKSRSTDVGSRADG | 991 | Q5SW79 | |
| GVESADSRRLATKHS | 246 | P50406 | |
| KIKVSSSERHSSSDE | 526 | O60583 | |
| TEHLSDQDKSRSKAG | 281 | Q6ZTN6 | |
| SSKRSSRSVEDDKEG | 276 | P49761 | |
| GKTKDHRRSSSSRSQ | 471 | Q92625 | |
| RVDRKRKVSGDSSHT | 1131 | Q6W2J9 | |
| RDVSKEDHSKRSSFV | 101 | P42574 | |
| KSVHREESCSDSGTK | 1371 | Q5T5Y3 | |
| SSSSSRKDRDSKAHR | 266 | Q14004 | |
| RKENHSSEGTKESSS | 636 | Q8NDT2 | |
| ESTSSSGRKSKRNEE | 66 | A4D1F6 | |
| ESKESVGSRDSSKRE | 471 | Q66K74 | |
| SDSKSQSRRHLSAKE | 806 | O60524 | |
| KDRVSERSSAGAHKT | 1326 | Q15652 | |
| SVTTGKHKDAATDSR | 1426 | Q8IVV2 | |
| DTKVDSSPRRKHSSS | 821 | Q5T0W9 | |
| ESKSSGSSHARIKSR | 441 | Q5SYE7 | |
| EESSHKKSRLSSAEE | 241 | Q70Z53 | |
| ERSHKSSKGGSSRDT | 661 | Q9H307 | |
| HDLGAASVRSTKTEK | 1326 | O96028 | |
| RRAKGKDQTSSHNSS | 91 | Q49A26 | |
| KGSVERRSEKDSSHS | 526 | Q86SU0 | |
| RTGKRKRSSSEDAES | 291 | Q4G0J3 | |
| SLKEKEEDSSGHTRA | 541 | P52701 | |
| KEASSESSGHKRSSS | 466 | Q2PPJ7 | |
| KKSTHRRGICEDESS | 296 | Q9GZU2 | |
| SDEHPGSSVASKSRK | 406 | Q6ZV29 | |
| SSKEARTSDKHDSTR | 1446 | Q7Z6E9 | |
| SKKRRHKSDSPESDA | 876 | O75400 | |
| REGKEHDLSVSSDST | 276 | Q9BZF1 | |
| TDRGSESDKHFRKVS | 196 | O60313 | |
| DSTSTRLERKLSDGH | 1006 | Q8NFC6 | |
| KEVDSSHEKARGNSS | 1046 | Q8NFC6 | |
| HKKSRERDGNERDSS | 86 | Q9P0U4 | |
| RKTSSRSDHGTESKL | 941 | Q6AI39 | |
| NRKEKTHSIRSTEGD | 281 | Q5R3K3 | |
| SRREVKAESSGKSHR | 91 | Q8NFT6 | |
| KTSSSQHSDKSEEAR | 1476 | Q8N3K9 | |
| TGRKKSSSHDSGTDI | 931 | Q03164 | |
| TSADHKLQSRRSGKD | 406 | Q86VF2 | |
| SDRSFRRKKDSVESH | 301 | Q5T9C2 | |
| HRERPRKDSESKSSS | 201 | Q03111 | |
| EEGRSSRHSKSSSDR | 71 | O43395 | |
| RGTSDEHEASRRVKS | 316 | Q9BW62 | |
| RSKEGRRHESKDKSS | 66 | Q7L4I2 | |
| KEHSSDKGRERLNSS | 91 | Q7L4I2 | |
| SPSRSVSKEREHAKS | 406 | Q08170 | |
| EDRSSSSSSEGKEKH | 171 | Q8TA86 | |
| NGASRSSKDISKDHL | 146 | Q9ULS5 | |
| SKSISRQSEKAHSSG | 431 | P12757 | |
| SKSESEDSIRRKSFH | 501 | Q15858 | |
| KDKERSSSKECSGHS | 501 | Q8IX21 | |
| RSRSSHKDSPRDVSK | 966 | O15042 | |
| GDHRESKKSRSHSAK | 131 | Q9NY61 | |
| RETSGEKKRSGHSDS | 906 | Q9UKE5 | |
| EASGTSSEKGRTKRE | 636 | O95625 | |
| SSHSRERSAEKTEKT | 746 | Q9Y2W1 | |
| KARSRDSDESGDKTT | 236 | Q5JTV8 | |
| SDSESDTGKRARHTS | 206 | Q9NP64 | |
| DTGKRARHTSKDSKA | 211 | Q9NP64 | |
| HKATSSSRSEPEGRK | 3016 | O60673 | |
| SEKKHGADRSGSTAV | 116 | P35813 | |
| RSHSKTRVSKGDPSD | 371 | Q9P2F5 | |
| HAKSKREEAADRSSE | 496 | Q5VZP5 | |
| SRSKERSHKRDHSDS | 501 | Q5VTL8 | |
| SSTEDKGRLLHSSKE | 1276 | Q9UGU0 | |
| VRHKSASNGSKTDTE | 1751 | Q9UGU0 | |
| RARSTNVHSKTSGDK | 2176 | Q8IUG5 | |
| KSSTHGEAAAETDSR | 106 | Q96T88 | |
| AQEASKSASHKGSRR | 851 | Q5SXM2 | |
| RSRSHSKTMGRKESE | 571 | Q92609 | |
| EESLDKTSHSVGRRA | 1306 | Q12789 | |
| SSQGHRKDSDKSRSR | 51 | Q8NDX6 | |
| TKSSSKRDHRRSVDS | 861 | Q8NFY4 | |
| GRGSKAEDEDKSHSR | 456 | Q8NA31 | |
| KRKTHRSTESGDAFH | 156 | P52741 | |
| SSSRKHDSIKDDSED | 216 | Q05513 | |
| DKDEDTHSRKSTVTD | 351 | Q01538 | |
| EVKGTTSSRSFKHSR | 186 | Q96NY8 |